XML 31 R18.htm IDEA: XBRL DOCUMENT
v3.21.1

GOODWILL AND INTANGIBLE ASSETS | 12 Months Ended
--- | ---
Apr. 03, 2021
Goodwill and Intangible Assets Disclosure [Abstract] |
GOODWILL AND INTANGIBLE ASSETS | GOODWILL AND INTANGIBLE ASSETSEffective as of March 31, 2019, the Company revised the composition of its reportable segments to align with its three global business units, Plasma, Blood Center and Hospital. Refer to Note 18, Segment and Enterprise-Wide Information, for additional information regarding the change in the Company's reportable segments. A reporting unit is defined as an operating segment or one level below an operating segment, referred to as a component. The Company aggregates components within an operating segment that have similar economic characteristics. Consistent with its reportable segments, reporting units for purposes of assessing goodwill impairment have also been reorganized based on business unit and include: Plasma, Blood Center and Hospital. To determine the amount of goodwill within each of the new reporting units, the Company reallocated, on a relative fair value basis, $84.0 million of goodwill previously allocated to the former Europe, APAC and Japan reporting units to the new global reporting units. In addition, the $126.8 million of goodwill previously allocated to the former North America reporting units was reallocated to each new respective global reporting unit. The following represents the Company's goodwill balance by new global reportable segment for fiscal 2021 and 2020. The prior period information has been restated to conform to the current presentation:
(In thousands) | Plasma |  | Blood Center |  | Hospital |  | Total
Carrying amount as of March 30, 2019 | $ | 28,979 |  |  | $ | 36,666 |  |  | $ | 145,174 |  |  | $ | 210,819 |
Currency translation | — |  |  | (34) |  |  | (133) |  |  | (167) |
Carrying amount as of March 28, 2020 | 28,979 |  |  | 36,632 |  |  | 145,041 |  |  | 210,652 |
Divestitures | — |  |  | (2,181) |  |  | (2,853) |  |  | (5,034) |
Acquisitions | — |  |  | — |  |  | 259,788 |  |  | 259,788 |
Currency translation | 64 |  |  | 77 |  |  | 897 |  |  | 1,038 |
Carrying amount as of April 3, 2021 | $ | 29,043 |  |  | $ | 34,528 |  |  | $ | 402,873 |  |  | $ | 466,444 |
The results of the Company's goodwill impairment test performed in the fourth quarter of fiscal 2021, 2020 and 2019 indicated that the estimated fair value of all reporting units exceeded their respective carrying values. There were no reporting units at risk of impairment as of the fiscal 2021, 2020 and 2019 annual test dates. The gross carrying amount of intangible assets and the related accumulated amortization as of April 3, 2021 and March 28, 2020 is as follows:
(In thousands) | Gross Carrying Amount |  | Accumulated Amortization |  | Net
As of April 3, 2021 |  |  |  |  |
Amortizable: |  |  |  |  |
Patents | $ | 10,482 |  |  | $ | 8,897 |  |  | $ | 1,585 |
Capitalized software | 71,575 |  |  | 43,858 |  |  | 27,717 |
Other developed technology | 381,166 |  |  | 95,518 |  |  | 285,648 |
Customer contracts and related relationships | 204,701 |  |  | 168,446 |  |  | 36,255 |
Trade names | 9,516 |  |  | 3,921 |  |  | 5,595 |
Total | $ | 677,440 |  |  | $ | 320,640 |  |  | $ | 356,800 |
Non-amortizable: |  |  |  |  |
In-process software development | $ | 4,007 |  |  |  |  |
In-process patents | 4,676 |  |  |  |  |
Total | $ | 8,683 |  |  |  |  |
(In thousands) | Gross Carrying Amount |  | Accumulated Amortization |  | Net
As of March 28, 2020 |  |  |  |  |
Amortizable: |  |  |  |  |
Patents | $ | 9,878 |  |  | $ | 8,653 |  |  | $ | 1,225 |
Capitalized software | 76,740 |  |  | 43,022 |  |  | 33,718 |
Other developed technology | 138,283 |  |  | 81,822 |  |  | 56,461 |
Customer contracts and related relationships | 193,797 |  |  | 158,890 |  |  | 34,907 |
Trade names | 5,141 |  |  | 4,555 |  |  | 586 |
Total | $ | 423,839 |  |  | $ | 296,942 |  |  | $ | 126,897 |
Non-amortizable: |  |  |  |  |
In-process software development | $ | 2,563 |  |  |  |  |
In-process patents | 3,646 |  |  |  |  |
Total | $ | 6,209 |  |  |  |  |
During the fourth quarter of fiscal 2021, the Company acquired Cardiva and recorded $230.3 million of developed technology, $18.2 million of customer relationships, and $5.4 million of trademarks based on our preliminary purchase accounting valuation. During the first quarter of fiscal 2021, the Company acquired enicor and recorded $13.4 million of developed technology, $0.3 million of customer relationships, and $0.3 million of trademarks. Refer to Note 4, Acquisitions, for additional information regarding these acquisitions. Intangible assets include the value assigned to license rights and other developed technology, patents, customer contracts and relationships and trade names. The estimated useful lives for all of these intangible assets are approximately 5 to 15 years. The changes to the net carrying value of the Company's intangible assets from March 28, 2020 to April 3, 2021 reflect the impact of acquisitions and investments in capitalized software, partially offset by amortization expense. Aggregate amortization expense for amortized intangible assets for fiscal 2021, 2020, and 2019 was $41.2 million, $34.2 million and $32.6 million, respectively. There were no intangible asset impairments during fiscal 2021, 2020, and 2019. Future annual amortization expense on intangible assets is estimated to be as follows:
(In thousands) |  |
Fiscal 2022 |  | $ | 53,672 |
Fiscal 2023 |  | $ | 39,371 |
Fiscal 2024 |  | $ | 34,937 |
Fiscal 2025 |  | $ | 27,582 |
Fiscal 2026 |  | $ | 22,247 |
For costs incurred related to the development of software to be sold, leased, or otherwise marketed, the Company applies the provisions of ASC Topic 985-20, Software - Costs of Software to be Sold, Leased or Marketed, which specifies that costs incurred internally in researching and developing a computer software product should be charged to expense until technological feasibility has been established for the product. Once technological feasibility is established, all software costs should be capitalized until the product is available for general release to customers. The costs capitalized for each project are included in intangible assets in the consolidated financial statements. The Company capitalized $4.2 million and $3.9 million in software development costs for ongoing initiatives during fiscal 2021 and 2020, respectively. At April 3, 2021 and March 28, 2020, the Company had a total of $75.6 million and $79.3 million of software costs capitalized, of which $4.0 million and $2.6 million are related to in process software development initiatives, respectively, and the remaining balance represents in-service assets that are being amortized over their useful lives. Amortization expense for capitalized software was $7.8 million, $8.2 million, and $7.6 million for the fiscal years ended April 3, 2021, March 28, 2020, and March 30, 2019, respectively.

X
- References No definition available. + Details
Name: | us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for goodwill and intangible assets. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -URI http://asc.fasb.org/topic&trid=2144416 + Details
Name: | us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration